Hemorrhoid Master
NDC 72654-002, LIDOCAINE, PHENYLEPHRINE, ointment, from Ebanel Laboratories, Inc.
- Product NDC
- 72654-002
- Status
- Listed
- Labeler
- Ebanel Laboratories, Inc
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M017
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72654-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIDOCAINE40 mg/g
- PHENYLEPHRINE2.5 mg/g
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72654-002-01 | 72654000201 | 45 g in 1 TUBE (72654-002-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 72654-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72654-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72654-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.